Patient analysis software producer BostonGene has received $50m from NEC in the form of a series A investment that will fund hiring and technology development.
IT and network technology producer NEC Corporation provided $50m of series A funding for US-based medical analytics software provider BostonGene Corporation yesterday.
Founded in 2015, BostonGene produces biomedical software for use with cancer patients. It forms a molecular profile of each patient using genome sequencing technology and calculates the nature of their cancer and state of their immune system.
Once an individual profile has been established, medical professionals can access an artificial intelligence-equipped database of cancer research and prescribe a…
